Efficacy and safety of propranolol on the proliferative phase of infantile hemangioma: A hospital-based prospective study
Background: Propranolol may be more effective and safer than previously established therapies, and it may be used as a first-line therapy for infantile hemangioma (IH). Propranolol is thought to inhibit the growth of blood vessels by decreasing vascular endothelial growth factor. Aims and Objectives...
Saved in:
Main Authors: | Jignaben Krunal Padhiyar (Author), Nayan H Patel (Author), Trusha P Gajjar (Author), Mansi D Buch (Author), Yogesh B Shah (Author), Rekha Solanki (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A distinct clinicopathological presentation of cutaneous dermatophytosis mimicking autoimmune blistering disorder
by: Jignaben Krunal Padhiyar, et al.
Published: (2018) -
Dego's disease in a female child with Anti-Scl-70 antibody positivity
by: Jigna Krunal Padhiyar, et al.
Published: (2018) -
Unusual presentations and associations of hyper IgE Syndrome: Retrospective analysis of ten cases at tertiary care institute - With review of indian published reports
by: Nayan H Patel, et al.
Published: (2018) -
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011) -
Novel marker in proliferative and involuting phases of infantile hemangioma
by: Neveen E Sorour, et al.
Published: (2020)